UK based cardiologist and anti-vaxxer Aseem Malhotra's visit to South Africa has raised public safety concerns among clinicians, scientists, and public health specialists in South Africa and beyond.
The level of research and investment poured into Covid-19 should also be applied to other deadly, infectious disease killers, such as TB, say SA experts.
While there are nine experimental tuberculosis vaccines in advanced trials, the vaccine pipeline beyond those nine prospects is relatively depleted. Adele Baleta reports on the virtual Global Forum on TB Vaccines held last week.
While there are nine experimental tuberculosis (TB) vaccines in advanced trials, the vaccine pipeline beyond those nine prospects is relatively depleted.
Glimmer of hope for vaccine that could eradicate TB reinfection 17 December 2020 - 20:07
Dose of optimism Local researchers hope to end TB re-infection if a new TB vaccine candidate is successful. It was proven to be safe and induced an immune response in patients. Image: Alaister Russell/The Sunday Times
Tuberculosis reinfection may be a thing of the past if a vaccine that is being developed by the University of Cape Town researchers proves successful.
The results from a clinical trial that is investigating a candidate vaccine that prevents the recurrence of TB in people who’ve recovered from the disease shows promise after it was proved safe and induced an immune response when given to cured patients.